Literature DB >> 33511435

No secret hiding place? Absence of SARS-CoV-2 on the ocular surface of 1145 hospitalized patients in a pandemic area.

Alexander C Rokohl1, Rafael S Grajewski2, Philomena A Wawer Matos2, Hannah-Leah Koch2, Felix Dewald3, Florian Klein3, Gerd Fätkenheuer4,5,6, Clara Lehmann4,5,6, Claus Cursiefen2,6, Ludwig M Heindl2.   

Abstract

OBJECTIVES: The aims of this study were to evaluate the isolated prevalence of real-time reverse transcriptase-polymerase chain reaction (RT-PCR)-confirmed SARS-CoV-2 on the ocular surface without systemic infection in hospitalized asymptomatic patients and to determine the risk for ophthalmologists and medical staff to be infected by prescreened asymptomatic patients in a tertiary eye care center.
METHODS: In this prospective, observational study, bilateral swaps of the conjunctiva in the lower fornices as well as nasopharyngeal swaps were collected in 1145 hospitalized asymptomatic patients of a tertiary eye care center. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) analysis was performed for each swap to evaluate the prevalence of SARS-CoV-2. Demographic data and potential risk factors for an isolated infection of the ocular surface were noted.
RESULTS: Two thousand two hundred eighty-eight (99.9%) of all 2290 tested eyes had negative results in the RT-PCR analysis of the conjunctival swabs. One patient had bilateral false-positive results in the conjunctival swabs. None of the 1145 patients had any positive RT-PCR-confirmed result in the nasopharyngeal swabs.
CONCLUSIONS: The risk for an isolated conjunctival viral activity in patients with a negative nasopharyngeal swab-based RT-PCR seems to be absent or extremely low, suggesting no need to perform additional conjunctival swabs in patients with negative nasopharyngeal swabs. Furthermore, the risk of a work-related SARS-CoV-2 infection due to direct contact with preselected asymptomatic patients in an eye care center is very low, especially when additional hygiene standards and safe distances are respected carefully. This might reassure medical staff and reduce the fear of SARS-CoV-2 infection.

Entities:  

Keywords:  COVID-19; Conjunctival swaps; Coronavirus; Nasopharyngeal swaps; Ocular surface; SARS-CoV-2

Mesh:

Substances:

Year:  2021        PMID: 33511435      PMCID: PMC7843237          DOI: 10.1007/s00417-021-05086-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  8 in total

1.  Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients.

Authors:  Maria Casagrande; Antonia Fitzek; Klaus Püschel; Ganna Aleshcheva; Heinz-Peter Schultheiss; Laura Berneking; Martin S Spitzer; Maximilian Schultheiss
Journal:  Ocul Immunol Inflamm       Date:  2020-05-29       Impact factor: 3.070

2.  Airborne pathogen projection during ophthalmic examination.

Authors:  Basak Bostanci Ceran; Alp Karakoç; Ertuğrul Taciroğlu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-06-25       Impact factor: 3.117

3.  Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.

Authors:  Camilla Rothe; Mirjam Schunk; Peter Sothmann; Gisela Bretzel; Guenter Froeschl; Claudia Wallrauch; Thorbjörn Zimmer; Verena Thiel; Christian Janke; Wolfgang Guggemos; Michael Seilmaier; Christian Drosten; Patrick Vollmar; Katrin Zwirglmaier; Sabine Zange; Roman Wölfel; Michael Hoelscher
Journal:  N Engl J Med       Date:  2020-01-30       Impact factor: 91.245

4.  Risk of SARS-CoV-2 transmission to medical staff and patients from an exposure to a COVID-19-positive ophthalmologist.

Authors:  Jaime Levy; Itay Chowers; Ori Saban
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-06-21       Impact factor: 3.117

Review 5.  [The role of ophthalmology in the COVID-19 pandemic].

Authors:  Alexander C Rokohl; Niklas Loreck; Philomena A Wawer Matos; Joel M Mor; Sarah Zwingelberg; Rafael S Grajewski; Claus Cursiefen; Ludwig M Heindl
Journal:  Ophthalmologe       Date:  2020-06-09       Impact factor: 1.059

6.  Conjunctivitis in COVID-19 patients: frequency and clinical presentation.

Authors:  Noemi Güemes-Villahoz; Barbara Burgos-Blasco; Julián García-Feijoó; Federico Sáenz-Francés; Pedro Arriola-Villalobos; Jose María Martinez-de-la-Casa; Jose Manuel Benítez-Del-Castillo; María Herrera de la Muela
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-29       Impact factor: 3.117

7.  Does hand hygiene reduce SARS-CoV-2 transmission?

Authors:  Chao Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-03-27       Impact factor: 3.117

8.  Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong.

Authors:  Tracy H T Lai; Emily W H Tang; Sandy K Y Chau; Kitty S C Fung; Kenneth K W Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-03-03       Impact factor: 3.535

  8 in total
  3 in total

1.  Tracing the SARS-CoV-2 infection on the ocular surface: Overview and preliminary corneoscleral transcriptome sequencing.

Authors:  Umberto Rosani; Claudia Del Vecchio; Elisa Franchin; Paola Brun; Stefano Ferrari; Diego Ponzin; Andrea Leonardi
Journal:  Exp Eye Res       Date:  2022-02-05       Impact factor: 3.770

2.  Detection of SARS-CoV-2-RNA in post-mortem samples of human eyes.

Authors:  Josef Penkava; Maximilian Muenchhoff; Irina Badell; Andreas Osterman; Claire Delbridge; Florian Niederbuchner; Sarah Soliman; Martina Rudelius; Alexander Graf; Stefan Krebs; Helmut Blum; Michael Ulbig; Carmen Baumann; Daniel Zapp; Mathias Maier; Oliver T Keppler; Chris P Lohmann; Stephan Ledderose
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-12-28       Impact factor: 3.117

3.  Detection of COVID-19 in tears of ICU-admitted patients with SARS-CoV-2 infection.

Authors:  Seyed Hashem Daryabari; Atieh Asadollah; Farhad Adhami Moghadam; Ruhollah Dorostkar; Ali Bahramifar; Hossein Aghamollaei
Journal:  Int Ophthalmol       Date:  2021-11-11       Impact factor: 2.029

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.